baber/WOPTO huggingface dataset:
Patent DK-1193266-T3 (DK)
Inventor: YAZAKI AKIRA
IPC: C07D401/14
Filed: 2000-06-22
Granted: 2003-11-24
Abstract: This invention relates to 1-(6-amino-3,5-difluoropyridin-2-yl)-8-bromo-7-(3-ethylaminoazetidin-1 -yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a salt thereof, and also to a medicine containing the same. This compound has characteristic features that, when administered orally, it has extremely high blood half-life and bioavailability while retaining properties that it has extremely high antimicrobial effects and has low toxicity. It can be used widely as preventives, therapeutics and the like for various infectious diseases of human and animals.
Patent DK-1206961-T3 (DK)
Inventor: IDE SHOICHI
IPC: A61L2/02
Filed: 2000-08-18
Granted: 2007-04-02
Abstract: Filter membranes to be used in efficiently eliminating pathogens such as viruses from solutions of drugs or physiologically active substances employed as starting materials thereof which are contaminated with pathogens such as viruses. These filter membranes, which can simultaneously achieve favorable performance of eliminating small viruses and a high physiologically active substance-permeability, can be obtained by controlling the membrane characteristics to give a ratio (BP/ gamma ) of the bubble point BP (MPa) to the surface tension  gamma  (N/m) of 110 or above, and/or logarithmic elimination ratios of swine parvovirus at 0 to 5 l/m<2> filtration and at 50 to 55 l/m<2> filtration of each 3 or above, and regulating the permeability for bovine immunoglobulin, wherein the monomer content amounts to at least 80%, to 70% or above. These filter membranes make it possible to provide drugs or starting materials therefor with little fear of the contamination with viruses, etc. and, therefore, are useful in the fields of pharmacy, medicine and the like.
Patent DK-1212987-T3 (DK)
Inventor: BUTARIC FRANK
IPC: A61F2/06
Filed: 2001-11-15
Granted: 2007-04-23
Abstract: In accordance with the present invention there is provided a stent graft for insertion into a body lumen, such as a blood vessel, in order to repair such lumen. The stent graft includes a substantially cylindrical hollow expandable stent comprising a plurality of interconnected struts. The stent has a distal end and a proximal end, and an interior surface and an exterior surface. At least one strut of the stent has first and second apertures extending therethrough from the interior surface to the exterior surface. The stent graft also includes a graft member covering a predetermined portion of least one of the interior surface and the exterior surface of the stent. In addition, the stent graft further includes a staple for attaching the graft member to the stent. The staple has a crown and two legs extending therefrom. At least one of the legs of the staple extends through the graft material and through the first aperture. Both of the legs are bent inwardly towards said crown such that they evert back and extend through the second aperture. <IMAGE>
Patent DK-1272272-T3 (DK)
Inventor: EIJSBOUTS SONJA
IPC: B01J27/188
Filed: 2001-04-05
Granted: 2012-03-05
Abstract: The present invention pertains to a process for sulfiding a catalyst composition comprising at least one hydrogenation metal component of Group VI and/or Group VIII of the Periodic Table, and an organic additive wherein the catalyst composition is first contacted with an organic liquid, followed by the catalyst being contacted with hydrogen and a sulfur-containing compound in the gaseous phase, wherein less than about 40%, preferably less than about 35%, more preferably less than about 25%, most preferably less than about 15%, of the sulfur present in the sulfided catalyst is added with the organic liquid. The process of the present invention makes it possible to use additive-containing catalysts without loss of activity in units which cannot effect gas phase start-up or are required to carry out a pressure test. The organic liquid may be a hydrocarbon with a boiling range of about 150-500° C., preferably gasoline, white spirit, diesel, gas oil, mineral lube oil, or white oil. The step of contacting the catalyst with hydrogen and a sulfur-containing compound may take place in one step at a temperature of about 150-450° C. It may also take place in two steps, with the first step being performed at a temperature which is lower than that of the second step, with the first step being carried out at a temperature of about 100-250° C. and the second step at a temperature of about 150-450° C.
Patent DK-1286641-T3 (DK)
Inventor: SCHROER FREDERIKUS JOHANNES
IPC: A61B17/12
Filed: 2001-06-07
Granted: 2005-01-24
Abstract: Vasoregulation device for use during the phase prior to headache, in particular migraine, for applying pressure at least locally to one or more veins on the outside of the head, in order to restrict the flow of blood through the said veins, at least comprising pressure-exerting means where is said pressure-exerting means are designed to apply a pressure of 0,01 - 0,03 N/mm<2>. The device is thus intended for preventative use at the onset of migraine. <IMAGE>
Patent DK-1273288-T3 (DK)
Inventor: TIEMESSEN HARRY
IPC: C09K23/00
Filed: 1997-01-20
Granted: 2005-11-21
Abstract: A process for preparing an emulsion composition comprising an ascomycin or a derivative thereof as active agent, which process comprises the step of admixing to a placebo fat emulsion a concentrate comprisinga) the active agent,b) a stabiliser selected from a phospholipid, a glycolipid, a sphingolipid, a diacylphosphatidyl glycerol, an egg-phosphatidylglycerol, a soy-phosphatidylglycerol, or a salt thereof; or a saturated, mono- or di-unsaturated (C<sub>12-24</sub>) fatty acid, or a salt thereof, andc) an organic solvent,    wherein the weight ratio of acitve agent to stabiliser is between 400:1 and 0.5:1.The invention also provides ready-to-use emulsions, e.g. for intravenous administration, prepared using the above process.
Patent DK-1368689-T3 (DK)
Inventor: IPPOLITO KIM
IPC: G02B7/28
Filed: 2002-02-01
Granted: 2006-09-18
Abstract: The invention provides a method for a method for determining a best initial focal position estimate for a current sample location on a substrate comprising multiple sample locations, comprising determining the best initial focal position estimate by using a result from one or more techniques selected from the group consisting of linear regression analysis of focal positions determined for at least two other sample locations on the substrate and quadratic regression analysis of focal positions determined for at least three other sample locations on the substrate.
Patent DK-1420847-T3 (DK)
Inventor: TANGHOJ ALLAN
IPC: A61M25/16
Filed: 2002-06-28
Granted: 2009-05-04
Abstract: The present invention is a catheter assembly allowing for non-contaminated insertion of a catheter into a urinarycanal. The assembly includes a package for the catheter and an applicator to be used for guiding the catheter into the urinary canal without touching the catheter by holding the catheter via walls of the applicator. The assembly further comprises clamping means for pressing the walls of the applicator into engagement with the catheter. The present invention further relates to an applicator with integrated clamping means to be used with the assembly.
Patent DK-1432943-T3 (DK)
Inventor: DAVIDSON PAUL ANTHONY
IPC: F16L21/08
Filed: 2002-09-30
Granted: 2005-11-14
Abstract: An assembly for securing two bodies is described, the assembly comprises a first body, the first body having a mouth portion for receiving a second body, and means for securing the first body to the second body, and means for sealing the first body against the second body, the securing means comprising, a first securing member for engagement with the second body, wherein the first securing member is for at least partial location inside the mouth portion and has means for engagement with the first body thereby to prevent removal of the second body from the mouth portion of the first body. The assembly may be a connector for joining two or more pipes or a coupling for joining a pipe to an operating unit such as a vehicle braking system for example.
Patent DK-1352845-T3 (DK)
Inventor: MURARO PIERRE
IPC: B65B69/00
Filed: 2003-03-26
Granted: 2006-01-16
Abstract: The envelopes (3) are held between two rigid spacers (5, 7) at either end of the block (1). A wrapping (11, 110) is provided around the envelopes and spacers in order to hold them together.  Independent claims are also included for the following: (1) Combination of the envelope blocks, a pallet and a stretch film for holding the blocks on top of the pallet;  (2) Method for unwrapping the envelope blocks by removing a single piece of the wrapping, then removing the spacers and then loading the envelopes into a machine;  (3) Machine for wrapping envelopes, comprising a pincer with jaws for gripping the envelopes and spacers and a device for tying a wrapping around them; and  (4) Method for wrapping the envelopes using this machine.
Patent DK-1549329-T3 (DK)
Inventor: BRAEKMAN JEAN-CLAUDE
IPC: A61K36/27
Filed: 2003-10-09
Granted: 2007-05-07
Abstract: Extracts of the plant Calotropis procera, having a pharmacological activity, in particular an anti-poisonous activity, and active compounds isolated thereof are described. Furthermore, methods for the extraction of the extracts are disclosed. Also, a pharmaceutical composition or product for the treatment of cancer which includes an effective amount of the described extracts or an active compound thereof, a therapeutic compound and optionally a pharmaceutical acceptable carrier are described.
Patent DK-1546067-T3 (DK)
Inventor: ROCQUET PHILIPPE
IPC: A01N25/20
Filed: 2003-10-02
Granted: 2007-08-20
Abstract: The invention relates to a smoke composition comprising between 0.05 and 5% of one or more active ingredients, for an effective dose of active ingredient(s) of between 0.5 mg/m<SUP>3 </SUP>and 40 mg/m<SUP>3</SUP>, and a smoke base. According to the invention, the aforementioned smoke base comprises at least one oxidising agent, one reducing agent and one mineral filler. The mineral filler represents at least 25% of the weight of the base while the reducing agent represents at most 16% of the weight thereof, and the weight ratio of oxidising agent to reducing agent is at least 3/1.
Patent DK-1534455-T3 (DK)
Inventor: HUGHES RICHARD DAVID
IPC: B21J15/44
Filed: 2003-08-19
Granted: 2009-04-14
Abstract: Non-visible objects which differ in their physical properties from their surroundings by association with a variable strength magnetic field may be detected by a suitable array of Hall effect sensors which can be moved relative to the object in question. By analyzing the signals from the plurality of the sensors in the array, the position of the object can be deduced relative to the array and the array moved to enable a machining guide thereon to be aligned with the non-visible object. The system is of particular value in locating apertures (2) in wing spars (1) when attempting to fix the skin (3) of the wing on to them where it is important to be able to locate the correct point at which to drill a hole through the skin (3) to coincide with the hole (2) in the spar. By locating a magnet (4) relative to the hole to identify the hole magnetically and using an array of Hall sensors (12) in a base with an aperture (14), it is possible to shift the array (10) so that the aperture (14) is precisely aligned with the non-visible hole (2).
Patent DK-1454569-T3 (DK)
Inventor: ELZENBECK MANFRED
IPC: A47C1/032
Filed: 2004-03-02
Granted: 2006-03-20
Abstract: The chair is equipped with a seat carrying construction assembled of a swivel mounted front (6) and rear part. The seat can be adjusted regarding its level of inclination with a spring (27, 28), adjustable in length and swivel mounted between front (6) and rear part. The distance between the spring (27, 28) and the swivel axle is controlled with a rotating handle (42). The handle (42) is joined with a coupling element (39,40) designed as a bevel gear unit to the control device (36) resulting of the axles of the handle (42) and the control device (36) forming an angle.
Patent DK-1440667-T3 (DK)
Inventor: HUNT KENNETH WILLIAM
IPC: A61B46/23
Filed: 1998-09-09
Granted: 2006-04-10
Abstract: This invention relates to surgical drapes and in particular provides a drape which comprises a thin, flexible, adhesive-coated plastics film and a protective, releasable layer applied to the adhesive coating, the drape having an aperture through at least the adhesive-coated film to permit, in use, access to a wound area, at least one first edge of the drape having a non-adhesive coated handling bar for separating the adhesive-coated film from the protective layer, and wherein the protective layer comprises a separate strip extending parallel to the first edge of the drape, and which protects the adhesive coating in the region of the aperture and carries at least one flap overlapping the adjacent portion of the protective layer, said flap constituting a handle for facilitating removal of said strip prior to use.
Patent DK-1471073-T3 (DK)
Inventor: GERVASE BARBARA A
IPC: A61K39/00
Filed: 1991-11-07
Granted: 2009-01-26
Abstract: The following are claimed: (A) an isolated hepatitis C virus (HCV) a sialoglycoprotein (AG) selected from E1 and E2; (B) a method for purifying HCV AGs, which comprises (a) contacting a compsn. contg. HCV AGs with a mannose-binding protein, e.g. concanavalin A (ConA) or Galanthus nivalus agglutinin (GNA) and (b) isolating the portion of the compsn. which binds to the mannose-binding protein, e.g. by elution with mannose; (c) an assay kit for detecting the presence of HCV AGs, comprising (a) a solid support, (b) a mannose-binding protein, and (c) an antibody specific for the HCV AG, where one of the antibody and the mannose-binding protein is bound to the solid support; (D) a method for determining exposure to or infection by HCV, in which any HCV in a sample of body fluid is concd. by contact with a mannose-binding protein prior to assay; (E) a cell transformed with a vector for recombinant expression of a HCV AG, where the vector comprises a structural gene encoding a glycosoylation signal, a HCV AG, a regulatory sequence operable in the host cell and capable of regulating expressio fo the HCV AG, and a selectable marker, where the cell does not sialylate glycoproteins; and (F) a method for reducing or eliminatng the presence of HCV in plasma, serum or other biological liquids.
Patent DK-1587871-T3 (DK)
Inventor: COSMAN MICHAEL A
IPC: C08J5/00
Filed: 2004-01-28
Granted: 2010-01-18
Abstract: Preformed compositions comprising sulfur-containing polymers in shaped form and the use of preformed compositions in shaped form to seal apertures. In certain embodiments, the preformed compositions comprise a sulfur-containing polymer and a blend of fillers wherein the blend comprises substantially equal amounts of mica and polyamide.
Patent DK-1601852-T3 (DK)
Inventor: ANDERSEN JESPER
IPC: E06B9/02
Filed: 2004-02-16
Granted: 2008-03-03
Abstract: A foldable safety barrier to be secured in and removed from a door opening, comprising a frame having a covering member (28), such as a piece of fabric, said frame being formed by upper and lower cross members (1, 2) connected with first and second lateral posts (3, 4) by means of four angle brackets (5, 6, 7, 8), each of which has first and second legs, and constructed such that the upper (1) and lower (2) cross members consist of two pipes (9, 10) which are mutually displaceable, while the first and second lateral posts (3, 4) consist of two pipes (13, 14) which are interconnected by means of lockable hinge links (15, 19). The outer dimensions of the hinge links (15, 19) correspond to the outer dimensions of the lateral posts (3, 4). Two of the four angle brackets (5, 6, 7, 8) have arranged therein a threaded rod (29) having a ferrule (30) and optional pressure indicators, while a spring-biased threaded rod (24) having a ferrule (25) is arranged in the third angle bracket, and a housing (21) having a block movable in the housing (21) is arranged in the fourth angle bracket. The invention provides a foldable safety barrier having incorporated safety means, it being ensured that children cannot climb over the barrier as there are no faces on which the child can support its foot. Further, it can always be checked whether the barrier is fixed in a frame with a sufficient force.
Patent DK-1613434-T3 (DK)
Inventor: TRIFFETT BRETT
IPC: B03D1/14
Filed: 2004-03-12
Granted: 2011-09-05
Abstract: A method of measuring froth stability (as described herein) of a froth in a cell of a flotation circuit for a slurry of a mined mineral containing valuable material and gangue materials is disclosed. The method includes a step of measuring one or more than one froth stability parameter using a measurement column arranged to extend downwardly through the froth in the cell to a location below an interface between the froth and the slurry in the cell. A method of controlling the operation of a flotation cell that is based on the froth stability measurement method is also disclosed.
Patent DK-1694271-T3 (DK)
Inventor: GARONE LOUISE M
IPC: A61K/
Filed: 2004-09-02
Granted: 2011-09-12
Abstract: A novel FSH mutant with increased glycosylation and longer half-lifes for use in inducing folliculogenesis in human patients is described. The FSH mutant permits the use of lower cumulative doses of FSH to achieve the same or better clinical result.
Patent DK-1682810-T3 (DK)
Inventor: RYHMAN MORGAN
IPC: F16L37/098
Filed: 2004-11-04
Granted: 2008-09-22
Abstract: The arrangement is for coupling together two rigid tubular objects and comprises a male part and a female part (1). The female part comprises a socket, which at its one end is provided with a recess (3). The male part is tubular and at its one end has a cross edge, formed by a deepened formation in the male part outer wall. A socket-shaped component (11) is placed between the male part and the female part when the former is inserted in the latter. The socket-shaped component is provided with a spring tongue (12) with a first device (14) which on insertion of the socket-shaped component in the female component spring engages into its recess. The spring tongue allows separation of the female and male parts by rotation of the socket-shaped component relatively to the male part to a position where the spring tongue second devices are positioned radially outside the male component cross edge.
Patent DK-1733581-T3 (DK)
Inventor: CALVET JUAN CARLOS LOPEZ
IPC: G06K7/00
Filed: 2005-03-21
Granted: 2010-11-22
Abstract: The invention relates to a subscriber identity module for a mobile communication terminal, comprising a processing device, a memory device, an I/O device and a wireless communication device, in particular an interrogatable transponder such as an RFID transponder. The RFID transponder is operatively controllable by said processing device, and comprises a memory which contains identification data, configurable by the processing device. The RFID-enabled subscriber identification module may be used as an authentication token. A method for providing secure communications between the subscriber identification module and an RFID interrogating device is also provided.
Patent DK-1722947-T3 (DK)
Inventor: DELLRUP CLAES MAGNUS
IPC: B27G1/00
Filed: 2005-03-01
Granted: 2011-03-28
Abstract: The present invention relates to a process for repairing one or more damaged spots in a wooden part during the production of a wood-comprising article, which repair process comprises the steps of: filling in at least one damaged spot in the, preferably uncoated, wooden part with a radiation-curable composition, placing a radiation-permeable layer over at least one damaged spot filled in with the radiation-curable composition, curing the curable composition in said at least one damaged spot by irradiation through the radiation-permeable layer, and removing the radiation-permeable layer.
Patent DK-1773757-T3 (DK)
Inventor: APPENDINO GIOVANNI
IPC: A61P13/00
Filed: 2005-07-06
Granted: 2011-11-21
Abstract: The compounds of the general formula (I) in which X is represents two hydrogen atoms, a pi-bond, oxygen or methylene: R2 is a C<SUB>6</SUB>-C<SUB>12 </SUB>aryl, or arylalkyl residue: R3 is hydrogen, 2-hydroxyethyl or 2-aminoethyl are useful for the treatment of pathologies mediated by vanilloid receptors type I.
Patent DK-1882446-T3 (DK)
Inventor: MUELLER ACHIM
IPC: A61B5/00
Filed: 2006-07-24
Granted: 2009-01-12
Abstract: The device (112) has a measuring system (120) for measuring a property of analytes and/or change in a property of an ocular sensor (116) in an eye fluid caused by an analyte. A positioning system (122) measures a spatial position, which has a distance between a measurement site of an eye (114) and the device and an additional positioning coordinate. The positioning system has a camera system e.g. monocular or binocular camera system, and a triangulation system and a propagation time measuring system for 1-dimensional, 2-dimensional or 3-dimensional propagation time measurement. Independent claims are also included for the following: (1) a method of determining concentration of analytes in a body fluid using an analytical measuring system (2) a computer program with program codes, which, when executed on a computer or computer-network causes the computer or network to implement a method of determining concentration of analytes in a body fluid using an analytical measuring system.
Patent DK-1868954-T3 (DK)
Inventor: BERNARD JEAN-LUC
IPC: C03C13/00
Filed: 2006-03-31
Granted: 2009-02-02
Abstract: The invention relates to thermally-stable mineral wool which can dissolve in a physiological medium, comprising fibres containing the following constituents, expressed in percentage by weight, namely: 35-60 % SiO2, preferably 39-55 %; 12-27% Al2O3, preferably 16-25%; 0-35% CaO, preferably 3-25%; 0-30% MgO, preferably 0-15%; 0-17% Na2O, preferably 6-12%; 0-17% K2O, preferably 3-12%; 10-17% R2O (Na2O+K2O), preferably 12-17%; 0-5% P2O5, preferably 0-2%; 0-20% Fe2O3; 0-8% B2O3, preferably 0-4%; and 0-3% TiO2, and at least one phosphorous compound that can react with said fibres at a temperature of less than 1000° C. in order to form a coating on the surface thereof. The invention is characterised in that the phosphorous content of said compound, as expressed in phosphorus atom weight, varies between 0.0005%, in particular more than 0.01%, and 1%, in particular less than 0.5%, of the total weight of the fibres. The invention is also characterised in that a phosphorus compound is a molecule in which the phosphorus atom(s) are bound to at least one carbon atom either directly or by means of an oxygen atom.
Patent DK-1919869-T3 (DK)
Inventor: BINET JEAN
IPC: A61P25/00
Filed: 2006-08-29
Granted: 2010-08-02
Abstract: Indole derivatives (I), are new. Indole derivatives of formula (I) and their salts are new. R a, R bH, halo, 1-6C alkyl, CF 3, CN, COR 2, OR 2 or phenyl (optionally substituted by 1-4C alkyl or CF 3); R 21-4C alkyl, CF 3 or phenyl (optionally substituted by 1-4C alkyl or CF 3); R 2H or 1-4C alkyl; R : H or 1-3C alkyl; n : 1-3; X : a bond or O, and Ar 1phenyl, naphthyl, quinolinyl, isoquinolinyl, pyridinyl, pyrazolyl, imidazolyl, isoxazolyl, thiazolyl, benzothiazolyl, 2,1,3-benzothiadiazolyl, 3,4-dihydro-1,4-benzoxazinyl, 5,6,7,8-tetrahydronaphthlaneyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydroisoquinolinyl, 1,2,3,4-tetrahydro-2-oxoquinolinyl, 3,4-dihydro-2H-benzopyranyl, indolyl, 2,3-dihydroindolyl, 2,3-dihydrobenzofuranyl, 1,3-benzodioxolyl, 1,4-benzodioxanyl or benzoxazolyl (all optionally substituted by halo, 1-6C alkyl, CF 3, CN, CO-R 2, OR 2, NH-COR 2, morpholinyl, amino or 4-morpholinosulfonyl). Independent claims are included for the preparation of (I). [Image] ACTIVITY : Antilipemic; Antidiabetic; Cardiovascular-Gen.; Antiinflammatory; Neuroprotective; Nootropic; Antiparkinsonian; Anorectic; Antiarteriosclerotic; Cardiant; Hypotensive; Antiarthritic; Antirheumatic. MECHANISM OF ACTION : Peroxisome proliferator activated receptor (PPAR) activator. In a test used to determine activation of PPAR-alpha and/or PPAR-gamma , results showed that (I) exhibited an EC 50 value of 50 nM.